What is the relationship between Postural Orthostatic Tachycardia Syndrome (POTS) and Parkinson's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Patients with Parkinson's disease experiencing Postural Orthostatic Tachycardia Syndrome (POTS) symptoms should be managed with a combined approach of non-pharmacological and pharmacological interventions, prioritizing increased fluid intake, salt consumption, compression garments, and gradual physical reconditioning. When considering the management of POTS in patients with Parkinson's disease, it's crucial to understand the underlying autonomic dysfunction that affects both conditions, as highlighted in the study comparing ACC/AHA/HRS and ESC guidelines for the diagnosis and management of syncope 1. The guidelines define orthostatic intolerance and its various forms, including POTS, emphasizing the importance of recognizing these conditions in patients with autonomic dysfunction, such as those with Parkinson's disease.

Key non-pharmacological interventions include:

  • Increased fluid intake of 2-3 liters daily
  • Increased salt consumption of 8-10g daily
  • Use of compression garments for the lower body
  • Gradual physical reconditioning with recumbent exercises

If these measures are insufficient, pharmacological interventions may be considered, such as:

  • Fludrocortisone, starting at 0.1mg daily
  • Midodrine, 2.5-10mg three times daily
  • Pyridostigmine, 30-60mg three times daily
  • Beta-blockers like propranolol, 10-20mg twice daily, to control tachycardia, although they may worsen orthostatic hypotension

It's essential to monitor for worsening of Parkinson's symptoms, as autonomic dysfunction is common in both conditions, and treatment should be individualized and carefully monitored by healthcare providers familiar with both conditions, as the dysregulation of the autonomic nervous system can be exacerbated in Parkinson's disease due to alpha-synuclein deposits affecting autonomic ganglia and pathways 1.

From the Research

Pots and Parkinson Disease

  • POTS (Postural Orthostatic Tachycardia Syndrome) is a condition characterized by orthostatic intolerance with excessive heart rate increase without hypotension during upright posture 2.
  • Parkinson's disease is a neurological disorder that affects movement, with symptoms such as tremor, stiffness, and slowness 3.
  • There is no direct link between POTS and Parkinson's disease, but both conditions can have autonomic dysfunction as a common underlying factor 4, 2.

Autonomic Dysfunction in POTS and Parkinson's Disease

  • Autonomic dysfunction in POTS can lead to symptoms such as orthostatic intolerance, fatigue, and exercise intolerance 2.
  • Autonomic dysfunction in Parkinson's disease can lead to symptoms such as orthostatic hypotension, constipation, and urinary frequency 4, 3.
  • Treatment of autonomic dysfunction in both conditions often involves pharmacologic and non-pharmacologic approaches, such as increasing fluid and salt intake, and using medications like fludrocortisone and midodrine 4, 5.

Treatment of POTS and Parkinson's Disease

  • Treatment of POTS typically begins with patient education and non-pharmacologic treatment options, such as increasing fluid and salt intake, and using medications like beta-receptor antagonists and vasoconstrictors 6, 2.
  • Treatment of Parkinson's disease is symptomatic, focused on improvement in motor and nonmotor signs and symptoms, and often involves pharmacologic approaches like dopamine-based therapies and non-pharmacologic approaches like exercise and physical therapy 3.
  • There is no cure for either condition, but treatment can help manage symptoms and improve quality of life 4, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of dysautonomia associated with Parkinson's disease.

Parkinsonism & related disorders, 2009

Research

Fludrocortisone for orthostatic hypotension.

The Cochrane database of systematic reviews, 2021

Research

Postural tachycardia syndrome (POTS).

Journal of cardiovascular electrophysiology, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.